Cargando…
Inhibition of JNK-mediated autophagy enhances NSCLC cell sensitivity to mTORC1/2 inhibitors
As the activation of autophagy contributes to the efficacy of many anticancer therapies, deciphering the precise role of autophagy in cancer therapy is critical. Here, we report that the dual mTORC1/2 inhibitors PP242 and OSI-027 decreased cell viability but did not induce apoptosis in the non-small...
Autores principales: | Jin, Hyeon-Ok, Hong, Sung-Eun, Park, Jin-Ah, Chang, Yoon Hwan, Hong, Young Jun, Park, In-Chul, Lee, Jin Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928093/ https://www.ncbi.nlm.nih.gov/pubmed/27358039 http://dx.doi.org/10.1038/srep28945 |
Ejemplares similares
-
Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin
por: Jang, Se-Kyeong, et al.
Publicado: (2021) -
Correction to: Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin
por: Jang, Se-Kyeong, et al.
Publicado: (2021) -
An expanded role for mTORC1 in autophagy
por: Kim, Young-Mi, et al.
Publicado: (2015) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
por: Yang, Jin Young, et al.
Publicado: (2019)